nodes	percent_of_prediction	percent_of_DWPC	metapath
Nisoldipine—CYP1A2—chronic obstructive pulmonary disease	0.513	1	CbGaD
Nisoldipine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0471	0.209	CbGbCtD
Nisoldipine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0383	0.17	CbGbCtD
Nisoldipine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0259	0.115	CbGbCtD
Nisoldipine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0247	0.11	CbGbCtD
Nisoldipine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.022	0.0978	CbGbCtD
Nisoldipine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0215	0.0958	CbGbCtD
Nisoldipine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0203	0.0904	CbGbCtD
Nisoldipine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0129	0.0574	CbGbCtD
Nisoldipine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0122	0.0542	CbGbCtD
Nisoldipine—Clevidipine—CYP1A2—chronic obstructive pulmonary disease	0.00073	0.205	CrCbGaD
Nisoldipine—Nilvadipine—CYP1A2—chronic obstructive pulmonary disease	0.000655	0.184	CrCbGaD
Nisoldipine—Amlodipine—CYP1A1—chronic obstructive pulmonary disease	0.000585	0.164	CrCbGaD
Nisoldipine—Amlodipine—CYP1A2—chronic obstructive pulmonary disease	0.000564	0.158	CrCbGaD
Nisoldipine—Nifedipine—CYP1A1—chronic obstructive pulmonary disease	0.000523	0.147	CrCbGaD
Nisoldipine—Nifedipine—CYP1A2—chronic obstructive pulmonary disease	0.000504	0.142	CrCbGaD
Nisoldipine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00042	0.00199	CcSEcCtD
Nisoldipine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00042	0.00199	CcSEcCtD
Nisoldipine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00042	0.00199	CcSEcCtD
Nisoldipine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000418	0.00198	CcSEcCtD
Nisoldipine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000416	0.00197	CcSEcCtD
Nisoldipine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000413	0.00196	CcSEcCtD
Nisoldipine—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000411	0.00195	CcSEcCtD
Nisoldipine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00041	0.00194	CcSEcCtD
Nisoldipine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000407	0.00193	CcSEcCtD
Nisoldipine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000407	0.00193	CcSEcCtD
Nisoldipine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000406	0.00192	CcSEcCtD
Nisoldipine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000406	0.00192	CcSEcCtD
Nisoldipine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000404	0.00191	CcSEcCtD
Nisoldipine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000403	0.00191	CcSEcCtD
Nisoldipine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000403	0.00191	CcSEcCtD
Nisoldipine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000402	0.00191	CcSEcCtD
Nisoldipine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000399	0.00189	CcSEcCtD
Nisoldipine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000399	0.00189	CcSEcCtD
Nisoldipine—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.000397	0.00188	CcSEcCtD
Nisoldipine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000396	0.00188	CcSEcCtD
Nisoldipine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000392	0.00186	CcSEcCtD
Nisoldipine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000391	0.00185	CcSEcCtD
Nisoldipine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000389	0.00184	CcSEcCtD
Nisoldipine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000389	0.00184	CcSEcCtD
Nisoldipine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000387	0.00183	CcSEcCtD
Nisoldipine—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00183	CcSEcCtD
Nisoldipine—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00182	CcSEcCtD
Nisoldipine—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00182	CcSEcCtD
Nisoldipine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000384	0.00182	CcSEcCtD
Nisoldipine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000384	0.00182	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000382	0.00181	CcSEcCtD
Nisoldipine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000381	0.0018	CcSEcCtD
Nisoldipine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000381	0.0018	CcSEcCtD
Nisoldipine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00038	0.0018	CcSEcCtD
Nisoldipine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000379	0.0018	CcSEcCtD
Nisoldipine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000379	0.0018	CcSEcCtD
Nisoldipine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000377	0.00178	CcSEcCtD
Nisoldipine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000377	0.00178	CcSEcCtD
Nisoldipine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000374	0.00177	CcSEcCtD
Nisoldipine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000374	0.00177	CcSEcCtD
Nisoldipine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000371	0.00176	CcSEcCtD
Nisoldipine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000369	0.00175	CcSEcCtD
Nisoldipine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000367	0.00174	CcSEcCtD
Nisoldipine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000367	0.00174	CcSEcCtD
Nisoldipine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000367	0.00174	CcSEcCtD
Nisoldipine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.00172	CcSEcCtD
Nisoldipine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000362	0.00172	CcSEcCtD
Nisoldipine—Cough—Formoterol—chronic obstructive pulmonary disease	0.000362	0.00172	CcSEcCtD
Nisoldipine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000359	0.0017	CcSEcCtD
Nisoldipine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.0017	CcSEcCtD
Nisoldipine—Cough—Montelukast—chronic obstructive pulmonary disease	0.000355	0.00168	CcSEcCtD
Nisoldipine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000353	0.00167	CcSEcCtD
Nisoldipine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000353	0.00167	CcSEcCtD
Nisoldipine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000353	0.00167	CcSEcCtD
Nisoldipine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000353	0.00167	CcSEcCtD
Nisoldipine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000353	0.00167	CcSEcCtD
Nisoldipine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000353	0.00167	CcSEcCtD
Nisoldipine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000353	0.00167	CcSEcCtD
Nisoldipine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000353	0.00167	CcSEcCtD
Nisoldipine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000352	0.00167	CcSEcCtD
Nisoldipine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000352	0.00167	CcSEcCtD
Nisoldipine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.00167	CcSEcCtD
Nisoldipine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000352	0.00167	CcSEcCtD
Nisoldipine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00166	CcSEcCtD
Nisoldipine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.00165	CcSEcCtD
Nisoldipine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000349	0.00165	CcSEcCtD
Nisoldipine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.00164	CcSEcCtD
Nisoldipine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000346	0.00164	CcSEcCtD
Nisoldipine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000346	0.00164	CcSEcCtD
Nisoldipine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000345	0.00164	CcSEcCtD
Nisoldipine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000345	0.00164	CcSEcCtD
Nisoldipine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000345	0.00163	CcSEcCtD
Nisoldipine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000344	0.00163	CcSEcCtD
Nisoldipine—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000342	0.00162	CcSEcCtD
Nisoldipine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000342	0.00162	CcSEcCtD
Nisoldipine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.0016	CcSEcCtD
Nisoldipine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000339	0.0016	CcSEcCtD
Nisoldipine—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000338	0.0016	CcSEcCtD
Nisoldipine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.00158	CcSEcCtD
Nisoldipine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.00158	CcSEcCtD
Nisoldipine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.00158	CcSEcCtD
Nisoldipine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000333	0.00158	CcSEcCtD
Nisoldipine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.00157	CcSEcCtD
Nisoldipine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000332	0.00157	CcSEcCtD
Nisoldipine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000331	0.00157	CcSEcCtD
Nisoldipine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000331	0.00157	CcSEcCtD
Nisoldipine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00156	CcSEcCtD
Nisoldipine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000329	0.00156	CcSEcCtD
Nisoldipine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000328	0.00155	CcSEcCtD
Nisoldipine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.00155	CcSEcCtD
Nisoldipine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00151	CcSEcCtD
Nisoldipine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000316	0.0015	CcSEcCtD
Nisoldipine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000316	0.0015	CcSEcCtD
Nisoldipine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000315	0.00149	CcSEcCtD
Nisoldipine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.00149	CcSEcCtD
Nisoldipine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.00148	CcSEcCtD
Nisoldipine—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000312	0.00148	CcSEcCtD
Nisoldipine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000309	0.00146	CcSEcCtD
Nisoldipine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.00146	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.00146	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000309	0.00146	CcSEcCtD
Nisoldipine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00145	CcSEcCtD
Nisoldipine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00145	CcSEcCtD
Nisoldipine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.00144	CcSEcCtD
Nisoldipine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000304	0.00144	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000302	0.00143	CcSEcCtD
Nisoldipine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000302	0.00143	CcSEcCtD
Nisoldipine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000302	0.00143	CcSEcCtD
Nisoldipine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000301	0.00143	CcSEcCtD
Nisoldipine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000301	0.00143	CcSEcCtD
Nisoldipine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00142	CcSEcCtD
Nisoldipine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000299	0.00142	CcSEcCtD
Nisoldipine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.00142	CcSEcCtD
Nisoldipine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00141	CcSEcCtD
Nisoldipine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00141	CcSEcCtD
Nisoldipine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000298	0.00141	CcSEcCtD
Nisoldipine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000297	0.00141	CcSEcCtD
Nisoldipine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000295	0.0014	CcSEcCtD
Nisoldipine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000294	0.00139	CcSEcCtD
Nisoldipine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000294	0.00139	CcSEcCtD
Nisoldipine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000292	0.00138	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.00138	CcSEcCtD
Nisoldipine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00137	CcSEcCtD
Nisoldipine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000289	0.00137	CcSEcCtD
Nisoldipine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000289	0.00137	CcSEcCtD
Nisoldipine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.00136	CcSEcCtD
Nisoldipine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000285	0.00135	CcSEcCtD
Nisoldipine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000284	0.00135	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000283	0.00134	CcSEcCtD
Nisoldipine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000282	0.00134	CcSEcCtD
Nisoldipine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.00133	CcSEcCtD
Nisoldipine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000281	0.00133	CcSEcCtD
Nisoldipine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00028	0.00133	CcSEcCtD
Nisoldipine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00028	0.00132	CcSEcCtD
Nisoldipine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000279	0.00132	CcSEcCtD
Nisoldipine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000279	0.00132	CcSEcCtD
Nisoldipine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000279	0.00132	CcSEcCtD
Nisoldipine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00132	CcSEcCtD
Nisoldipine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000277	0.00131	CcSEcCtD
Nisoldipine—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000271	0.00128	CcSEcCtD
Nisoldipine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.00127	CcSEcCtD
Nisoldipine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000269	0.00127	CcSEcCtD
Nisoldipine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000268	0.00127	CcSEcCtD
Nisoldipine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000268	0.00127	CcSEcCtD
Nisoldipine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000265	0.00125	CcSEcCtD
Nisoldipine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000264	0.00125	CcSEcCtD
Nisoldipine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000264	0.00125	CcSEcCtD
Nisoldipine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000264	0.00125	CcSEcCtD
Nisoldipine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.00125	CcSEcCtD
Nisoldipine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000263	0.00125	CcSEcCtD
Nisoldipine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000262	0.00124	CcSEcCtD
Nisoldipine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000262	0.00124	CcSEcCtD
Nisoldipine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.0012	CcSEcCtD
Nisoldipine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000253	0.0012	CcSEcCtD
Nisoldipine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00118	CcSEcCtD
Nisoldipine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00118	CcSEcCtD
Nisoldipine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000249	0.00118	CcSEcCtD
Nisoldipine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000249	0.00118	CcSEcCtD
Nisoldipine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000249	0.00118	CcSEcCtD
Nisoldipine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000247	0.00117	CcSEcCtD
Nisoldipine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000244	0.00116	CcSEcCtD
Nisoldipine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00024	0.00113	CcSEcCtD
Nisoldipine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.00113	CcSEcCtD
Nisoldipine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000239	0.00113	CcSEcCtD
Nisoldipine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00112	CcSEcCtD
Nisoldipine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000235	0.00111	CcSEcCtD
Nisoldipine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000232	0.0011	CcSEcCtD
Nisoldipine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000232	0.0011	CcSEcCtD
Nisoldipine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000227	0.00108	CcSEcCtD
Nisoldipine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000226	0.00107	CcSEcCtD
Nisoldipine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000224	0.00106	CcSEcCtD
Nisoldipine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.00106	CcSEcCtD
Nisoldipine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000219	0.00104	CcSEcCtD
Nisoldipine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00104	CcSEcCtD
Nisoldipine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00102	CcSEcCtD
Nisoldipine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00101	CcSEcCtD
Nisoldipine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00101	CcSEcCtD
Nisoldipine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000213	0.00101	CcSEcCtD
Nisoldipine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000213	0.00101	CcSEcCtD
Nisoldipine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00101	CcSEcCtD
Nisoldipine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.001	CcSEcCtD
Nisoldipine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000212	0.001	CcSEcCtD
Nisoldipine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000212	0.001	CcSEcCtD
Nisoldipine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.001	CcSEcCtD
Nisoldipine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000209	0.000991	CcSEcCtD
Nisoldipine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000209	0.00099	CcSEcCtD
Nisoldipine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.000988	CcSEcCtD
Nisoldipine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000208	0.000984	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000976	CcSEcCtD
Nisoldipine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.000973	CcSEcCtD
Nisoldipine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00097	CcSEcCtD
Nisoldipine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.00096	CcSEcCtD
Nisoldipine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000202	0.000956	CcSEcCtD
Nisoldipine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.000955	CcSEcCtD
Nisoldipine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000202	0.000955	CcSEcCtD
Nisoldipine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.000954	CcSEcCtD
Nisoldipine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000201	0.000953	CcSEcCtD
Nisoldipine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.000953	CcSEcCtD
Nisoldipine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.000949	CcSEcCtD
Nisoldipine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.000936	CcSEcCtD
Nisoldipine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000197	0.000933	CcSEcCtD
Nisoldipine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.0009	CcSEcCtD
Nisoldipine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.000895	CcSEcCtD
Nisoldipine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.000869	CcSEcCtD
Nisoldipine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.000855	CcSEcCtD
Nisoldipine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.000848	CcSEcCtD
Nisoldipine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.00084	CcSEcCtD
Nisoldipine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000786	CcSEcCtD
Nisoldipine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000785	CcSEcCtD
Nisoldipine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.00078	CcSEcCtD
Nisoldipine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000718	CcSEcCtD
Nisoldipine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.000716	CcSEcCtD
Nisoldipine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000715	CcSEcCtD
Nisoldipine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000707	CcSEcCtD
Nisoldipine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000698	CcSEcCtD
Nisoldipine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000695	CcSEcCtD
Nisoldipine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000694	CcSEcCtD
Nisoldipine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.00069	CcSEcCtD
Nisoldipine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00068	CcSEcCtD
Nisoldipine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000659	CcSEcCtD
Nisoldipine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000659	CcSEcCtD
Nisoldipine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000656	CcSEcCtD
Nisoldipine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000651	CcSEcCtD
Nisoldipine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.00064	CcSEcCtD
Nisoldipine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000631	CcSEcCtD
Nisoldipine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000621	CcSEcCtD
Nisoldipine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000616	CcSEcCtD
Nisoldipine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00061	CcSEcCtD
Nisoldipine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000602	CcSEcCtD
Nisoldipine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.00265	CbGpPWpGaD
Nisoldipine—CYP3A7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.00264	CbGpPWpGaD
Nisoldipine—CACNB2—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.000124	0.0026	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000123	0.00259	CbGpPWpGaD
Nisoldipine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.00259	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—APIP—chronic obstructive pulmonary disease	0.000122	0.00256	CbGpPWpGaD
Nisoldipine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000575	CcSEcCtD
Nisoldipine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.000574	CcSEcCtD
Nisoldipine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000571	CcSEcCtD
Nisoldipine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000567	CcSEcCtD
Nisoldipine—CACNA1D—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.000117	0.00246	CbGpPWpGaD
Nisoldipine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000556	CcSEcCtD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000116	0.00244	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.00243	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.00243	CbGpPWpGaD
Nisoldipine—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.00243	CbGpPWpGaD
Nisoldipine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000549	CcSEcCtD
Nisoldipine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000548	CcSEcCtD
Nisoldipine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000547	CcSEcCtD
Nisoldipine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000544	CcSEcCtD
Nisoldipine—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000114	0.0024	CbGpPWpGaD
Nisoldipine—CACNA1D—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000114	0.00239	CbGpPWpGaD
Nisoldipine—CACNA1C—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000113	0.00238	CbGpPWpGaD
Nisoldipine—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000113	0.00237	CbGpPWpGaD
Nisoldipine—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000111	0.00233	CbGpPWpGaD
Nisoldipine—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00011	0.0023	CbGpPWpGaD
Nisoldipine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00052	CcSEcCtD
Nisoldipine—CACNB2—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000109	0.00229	CbGpPWpGaD
Nisoldipine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000516	CcSEcCtD
Nisoldipine—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000109	0.00228	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000107	0.00224	CbGpPWpGaD
Nisoldipine—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000107	0.00223	CbGpPWpGaD
Nisoldipine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000502	CcSEcCtD
Nisoldipine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000499	CcSEcCtD
Nisoldipine—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000105	0.0022	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000104	0.00217	CbGpPWpGaD
Nisoldipine—CACNA1C—NCAM signaling for neurite out-growth—IL6—chronic obstructive pulmonary disease	0.000103	0.00216	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000102	0.00214	CbGpPWpGaD
Nisoldipine—CACNA1C—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.0001	0.0021	CbGpPWpGaD
Nisoldipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	9.97e-05	0.00209	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	9.95e-05	0.00209	CbGpPWpGaD
Nisoldipine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	9.84e-05	0.00206	CbGpPWpGaD
Nisoldipine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.82e-05	0.000465	CcSEcCtD
Nisoldipine—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.79e-05	0.00205	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.71e-05	0.00204	CbGpPWpGaD
Nisoldipine—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.66e-05	0.00202	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	9.51e-05	0.00199	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	9.46e-05	0.00198	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—GC—chronic obstructive pulmonary disease	9.45e-05	0.00198	CbGpPWpGaD
Nisoldipine—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.43e-05	0.000447	CcSEcCtD
Nisoldipine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.39e-05	0.00197	CbGpPWpGaD
Nisoldipine—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.28e-05	0.00195	CbGpPWpGaD
Nisoldipine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.26e-05	0.00194	CbGpPWpGaD
Nisoldipine—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.24e-05	0.00194	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.2e-05	0.00193	CbGpPWpGaD
Nisoldipine—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.16e-05	0.00192	CbGpPWpGaD
Nisoldipine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.12e-05	0.000432	CcSEcCtD
Nisoldipine—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.11e-05	0.00191	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	9.11e-05	0.00191	CbGpPWpGaD
Nisoldipine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.96e-05	0.00188	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—GC—chronic obstructive pulmonary disease	8.94e-05	0.00187	CbGpPWpGaD
Nisoldipine—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.81e-05	0.000417	CcSEcCtD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	8.81e-05	0.00185	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.78e-05	0.00184	CbGpPWpGaD
Nisoldipine—Rash—Prednisone—chronic obstructive pulmonary disease	8.4e-05	0.000398	CcSEcCtD
Nisoldipine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.4e-05	0.000398	CcSEcCtD
Nisoldipine—Headache—Prednisone—chronic obstructive pulmonary disease	8.35e-05	0.000395	CcSEcCtD
Nisoldipine—CACNA1D—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.32e-05	0.00174	CbGpPWpGaD
Nisoldipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	8.08e-05	0.00169	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.08e-05	0.00169	CbGpPWpGaD
Nisoldipine—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	7.93e-05	0.00166	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—LEP—chronic obstructive pulmonary disease	7.93e-05	0.00166	CbGpPWpGaD
Nisoldipine—Nausea—Prednisone—chronic obstructive pulmonary disease	7.92e-05	0.000375	CcSEcCtD
Nisoldipine—CACNA1C—Metabolism—GC—chronic obstructive pulmonary disease	7.86e-05	0.00165	CbGpPWpGaD
Nisoldipine—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.7e-05	0.00161	CbGpPWpGaD
Nisoldipine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.61e-05	0.0016	CbGpPWpGaD
Nisoldipine—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.6e-05	0.00159	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	7.47e-05	0.00157	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	7.42e-05	0.00156	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.31e-05	0.00153	CbGpPWpGaD
Nisoldipine—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	7.29e-05	0.00153	CbGpPWpGaD
Nisoldipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.25e-05	0.00152	CbGpPWpGaD
Nisoldipine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.15e-05	0.0015	CbGpPWpGaD
Nisoldipine—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.08e-05	0.00148	CbGpPWpGaD
Nisoldipine—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.98e-05	0.00146	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—LEP—chronic obstructive pulmonary disease	6.8e-05	0.00143	CbGpPWpGaD
Nisoldipine—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.71e-05	0.00141	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.69e-05	0.0014	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—MMP9—chronic obstructive pulmonary disease	6.68e-05	0.0014	CbGpPWpGaD
Nisoldipine—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.62e-05	0.00139	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.62e-05	0.00139	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—LEP—chronic obstructive pulmonary disease	6.44e-05	0.00135	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	6.42e-05	0.00135	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—VEGFA—chronic obstructive pulmonary disease	6e-05	0.00126	CbGpPWpGaD
Nisoldipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.87e-05	0.00123	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—MMP9—chronic obstructive pulmonary disease	5.73e-05	0.0012	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—LEP—chronic obstructive pulmonary disease	5.66e-05	0.00119	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	5.44e-05	0.00114	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	5.44e-05	0.00114	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—MMP9—chronic obstructive pulmonary disease	5.42e-05	0.00114	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	5.4e-05	0.00113	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—EGFR—chronic obstructive pulmonary disease	5.4e-05	0.00113	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	5.22e-05	0.00109	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.17e-05	0.00108	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.16e-05	0.00108	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—VEGFA—chronic obstructive pulmonary disease	5.14e-05	0.00108	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.11e-05	0.00107	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	5.1e-05	0.00107	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—GCLC—chronic obstructive pulmonary disease	5.1e-05	0.00107	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.99e-05	0.00105	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.95e-05	0.00104	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.89e-05	0.00103	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.89e-05	0.00103	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.89e-05	0.00102	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—VEGFA—chronic obstructive pulmonary disease	4.87e-05	0.00102	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—GCLC—chronic obstructive pulmonary disease	4.83e-05	0.00101	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	4.81e-05	0.00101	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—MMP9—chronic obstructive pulmonary disease	4.77e-05	0.000999	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—MMP9—chronic obstructive pulmonary disease	4.77e-05	0.000999	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.71e-05	0.000986	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.66e-05	0.000977	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.66e-05	0.000977	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.65e-05	0.000976	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.64e-05	0.000973	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—EGFR—chronic obstructive pulmonary disease	4.63e-05	0.00097	CbGpPWpGaD
Nisoldipine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.58e-05	0.000959	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.47e-05	0.000938	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.42e-05	0.000927	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—CTGF—chronic obstructive pulmonary disease	4.41e-05	0.000924	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—EGFR—chronic obstructive pulmonary disease	4.38e-05	0.000919	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.29e-05	0.0009	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.29e-05	0.0009	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.29e-05	0.000899	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	4.28e-05	0.000897	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—VEGFA—chronic obstructive pulmonary disease	4.28e-05	0.000897	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.26e-05	0.000894	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—GCLC—chronic obstructive pulmonary disease	4.24e-05	0.00089	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.23e-05	0.000888	CbGpPWpGaD
Nisoldipine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.21e-05	0.000882	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—IL6—chronic obstructive pulmonary disease	4.15e-05	0.00087	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—MMP9—chronic obstructive pulmonary disease	4.09e-05	0.000857	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	4.07e-05	0.000854	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.06e-05	0.000851	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	4.06e-05	0.00085	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.04e-05	0.000847	CbGpPWpGaD
Nisoldipine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.99e-05	0.000836	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.93e-05	0.000823	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—CTGF—chronic obstructive pulmonary disease	3.87e-05	0.000812	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.87e-05	0.000811	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.85e-05	0.000807	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.85e-05	0.000807	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.79e-05	0.000794	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.67e-05	0.000769	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.67e-05	0.000769	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.58e-05	0.000751	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.58e-05	0.00075	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.58e-05	0.00075	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.57e-05	0.000748	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—IL6—chronic obstructive pulmonary disease	3.56e-05	0.000745	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.53e-05	0.00074	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.53e-05	0.000739	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	3.48e-05	0.000729	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.48e-05	0.000728	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.4e-05	0.000713	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.39e-05	0.00071	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—IL6—chronic obstructive pulmonary disease	3.37e-05	0.000706	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.37e-05	0.000706	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.34e-05	0.0007	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.3e-05	0.000692	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.29e-05	0.00069	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.29e-05	0.000689	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	3.25e-05	0.000682	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.25e-05	0.00068	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.23e-05	0.000678	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.19e-05	0.000669	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.15e-05	0.000659	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.13e-05	0.000656	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.12e-05	0.000654	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.12e-05	0.000653	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.11e-05	0.000652	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.08e-05	0.000645	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.05e-05	0.00064	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.98e-05	0.000624	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.98e-05	0.000624	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.96e-05	0.000621	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—IL6—chronic obstructive pulmonary disease	2.96e-05	0.00062	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.95e-05	0.000618	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.94e-05	0.000615	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.8e-05	0.000587	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.75e-05	0.000576	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.73e-05	0.000573	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.7e-05	0.000566	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.63e-05	0.000551	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.63e-05	0.00055	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.62e-05	0.000549	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	2.6e-05	0.000545	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.59e-05	0.000543	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.54e-05	0.000532	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.51e-05	0.000526	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.44e-05	0.000512	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.4e-05	0.000504	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	2.37e-05	0.000497	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.32e-05	0.000486	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.19e-05	0.000458	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.18e-05	0.000457	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.15e-05	0.000452	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—ALB—chronic obstructive pulmonary disease	2.12e-05	0.000444	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.11e-05	0.000443	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2.1e-05	0.000439	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.09e-05	0.000439	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.03e-05	0.000425	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—ALB—chronic obstructive pulmonary disease	2.01e-05	0.00042	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2e-05	0.00042	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.96e-05	0.000411	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.95e-05	0.000408	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—NOS3—chronic obstructive pulmonary disease	1.92e-05	0.000402	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.9e-05	0.000398	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.88e-05	0.000394	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.87e-05	0.000392	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.82e-05	0.000382	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.8e-05	0.000377	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—ALB—chronic obstructive pulmonary disease	1.76e-05	0.000369	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.71e-05	0.000359	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—NOS3—chronic obstructive pulmonary disease	1.69e-05	0.000353	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.67e-05	0.000351	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.66e-05	0.000348	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.65e-05	0.000345	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.62e-05	0.000339	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.59e-05	0.000333	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.58e-05	0.000331	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.55e-05	0.000325	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.5e-05	0.000315	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.43e-05	0.000301	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.42e-05	0.000297	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.32e-05	0.000276	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.3e-05	0.000272	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.29e-05	0.000271	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.26e-05	0.000263	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.21e-05	0.000254	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.19e-05	0.00025	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.000241	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.14e-05	0.00024	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.13e-05	0.000237	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.08e-05	0.000226	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.06e-05	0.000221	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.03e-05	0.000216	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.03e-05	0.000216	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.94e-06	0.000208	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.8e-06	0.000205	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.14e-06	0.000191	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.84e-06	0.000185	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.73e-06	0.000183	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.66e-06	0.000182	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.97e-06	0.000167	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.94e-06	0.000166	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.83e-06	0.000164	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	7.8e-06	0.000164	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	7.46e-06	0.000156	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.34e-06	0.000154	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.29e-06	0.000153	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.91e-06	0.000145	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.12e-06	0.000128	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.04e-06	0.000127	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	5.89e-06	0.000123	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.63e-06	0.000118	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.63e-06	0.000118	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.34e-06	0.000112	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.7e-06	9.85e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.5e-06	9.42e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.63e-06	7.6e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.47e-06	7.27e-05	CbGpPWpGaD
